HealthQuill Asthma
Sanofi S.A.ā€™s drug, at its highest dose, has failed to meet its targeted reduction in the yearly rate of worsening episodes in adults with moderate-to-severe asthma, according to a statement.
Drugs Health Pharma

Sanofiā€™s test drug to treat moderate-to-severe asthma fails to meet goalsĀ 

HQ Team April 17, 2025: Sanofi S.A.ā€™s drug, at its highest dose, has failed to meet its targeted reduction in the yearly rate.

Read More
Israelā€™s Teva Pharmaceutical Industries, and US-basedĀ Launch Therapeutics, have joined hands to speed up the development of an experimental asthma drug.
Drugs Health

New treatment for severe asthma attacks in 50 years

Bharti Jayshankar November 29, 2024: Around half a billion people live with asthma and chronic obstructive pulmonary disease (COPD). The Global Burden of.

Read More
Sixty percent of the patients treated with Pfizerā€™s Lorbrena drug, for a rare form of advanced lung cancer, were alive without disease progression after five years, according to company data.
Health Uncategorized

Review finds links between allergic diseases and mental health conditions

HQ Team November 15, 2024:Allergies are a source of great social and physical impairment for people suffering from them. Treatments are long-drawn, expensive.

Read More
The US Food and Drug Administration has greenlighted Pfizer Inc.ā€™s respiratory syncytial virus vaccine (RSV) Abrysvo for treating lower respiratory tract disease in people 18-59 years.
Drugs Health Pharma

US drug regulator FDA approves expanded use of Pfizerā€™s RSV vaccine

The US Food and Drug Administration has greenlighted Pfizer Inc.ā€™s respiratory syncytial virus vaccine (RSV) Abrysvo for treating lower respiratory tract disease in.

Read More
Chinaā€™s drug regulator, the National Medical Products Association, has approved AstraZeneca Plcā€™s asthma drug.
Drugs Health Pharma

AstraZenecaā€™s asthma drug gets regulatorā€™s approval in China

Chinaā€™s drug regulator, the National Medical Products Association, has approvedĀ  AstraZeneca Plcā€™s asthma drug.

Read More
The European Medicines Agency has approved Sanofi S.A.ā€™s Dupixent (dupilumab) therapy as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease, according to a company statement.
Drugs Health Pharma

EMA approves Sanofiā€™s treatment for obstructive pulmonary disease

The European Medicines Agency has approved Sanofi S.A.ā€™s Dupixent (dupilumab) therapy as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary.

Read More
Johnson & Johnson will acquire Proteologix, Inc., a privately-held biotechnology company, for $850 million in cash, according to a statement.
Drugs Health Pharma

Johnson & Johnson to buy Proteologix Inc., for $850 million in cash

HQ Team May 17, 2024: Johnson & Johnson will acquire Proteologix, Inc., a privately-held biotechnology company, for $850 million in cash, according to.

Read More
Drugs Health Medical

NO2 in gas and propane stoves can cause asthma in children: Study

HQ Team May 4, 2024: A new research says that nitrogen dioxide gas (NO2) emitted by gas and propane stoves is likely to.

Read More
Israelā€™s Teva Pharmaceutical Industries, and US-basedĀ Launch Therapeutics, have joined hands to speed up the development of an experimental asthma drug.
Drugs Health Pharma

Israelā€™s Teva in pact with Launch Therapeutics for asthma drug

Israelā€™s Teva Pharmaceutical Industries, and US-basedĀ Launch Therapeutics, have joined hands to speed up the development of an experimental asthma drug.

Read More
British drugmaker GSK Plc., will pay $1.4 billion to acquire Anglo-American biopharmaceutical companyĀ  Aiolos Bio Inc., which makes medicines to treat asthma.
Drugs Health Pharma

GSK Plc., to buy asthma drugmaker Aiolos Bio for $1.4 billion Ā 

HQ Team January 9, 2023: British drugmaker GSK Plc., will pay $1.4 billion to acquire Anglo-American biopharmaceutical companyĀ  Aiolos Bio Inc., which makes.

Read More